Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

More articles from Research Article

  • The monoacylglycerol lipase inhibitor JZL184 inhibits lung cancer cell invasion and metastasis via the CB1 cannabinoid receptor
    Jan Lukas Prüser, Robert Ramer, Felix Wittig, Igor Ivanov, Jutta Merkord, Burkhard Hinz
    Molecular Cancer Therapeutics Jan 2021, molcanther.0589.2020; DOI: 10.1158/1535-7163.MCT-20-0589
  • Robust anti-tumor activity and low cytokine production by novel humanized anti-CD19 CAR-T cells
    Alka Dwivedi, Atharva Karulkar, Sarbari Ghosh, Srisathya Srinivasan, Bajarang Vasant Kumbhar, Ankesh Kumar Jaiswal, Atish Kizhakeyil, Sweety Asija, Afrin Rafiq, Sushant Kumar, Albeena Nisar, Deepali Pandit Patil, Minal Vivek Poojary, Hasmukh Jain, Shripad D Banavali, Steven L Highfill, David F Stroncek, Nirali N Shah, Terry J Fry, Gaurav Narula, Rahul Purwar
    Molecular Cancer Therapeutics Jan 2021, molcanther.MCT-20-0476-A.2020; DOI: 10.1158/1535-7163.MCT-20-0476
  • The discovery of a novel anti-metastatic Bcl3 inhibitor
    Jitka Soukupová, Cinzia Bordoni, Daniel J Turnham, William W Yang, Gillian Seaton, Aleksandra Gruca, Rhiannon French, Kok Yung Lee, Athina Varnava, Luke Piggott, Richard W. E. Clarkson, Andrew D Westwell, Andrea Brancale
    Molecular Cancer Therapeutics Jan 2021, molcanther.0283.2020; DOI: 10.1158/1535-7163.MCT-20-0283
  • Phenotypic models of CAR-T cell activation elucidate the pivotal regulatory role of CAR down-modulation
    Yoram Reiter, Raanan Greenman, Yoav Pizam, Maya Haus-Cohen, Guy Horev, Galit Denkberg, Shai Shen-Orr, Jacob Rubinstein
    Molecular Cancer Therapeutics Jan 2021, molcanther.MCT-19-1110-A.2019; DOI: 10.1158/1535-7163.MCT-19-1110
  • Discovery of JNJ-63576253, a next-generation androgen receptor antagonist active against wild-type and clinically-relevant ligand binding domain mutations in mCRPC
    Jonathan R. Branch, Tammy L. Bush, Vineet Pande, Peter J Connolly, Zhuming Zhang, Ian Hickson, Janine Ondrus, Steffen Jaensch, James R. Bischoff, Georges Habineza, Geert Van Hecke, Lieven Meerpoel, Kathryn Packman, Christopher J. Parrett, Yolanda T. Chong, Marco M. Gottardis, Gilles Bignan
    Molecular Cancer Therapeutics Jan 2021, molcanther.MCT-20-0510-A.2020; DOI: 10.1158/1535-7163.MCT-20-0510
  • TARGETING EYA3 IN EWING SARCOMA RETARDS TUMOR GROWTH AND ANGIOGENESIS
    Yuhua Wang, Ram Naresh Pandey, Kaushik Roychoudhury, David Milewski, Tanya V. Kalin, Sara Szabo, Joseph G Pressey, Rashmi S Hegde
    Molecular Cancer Therapeutics Jan 2021, molcanther.0749.2020; DOI: 10.1158/1535-7163.MCT-20-0749
  • Shaping Functional Avidity of CAR-T Cells: Affinity, Avidity and Antigen Density that Regulate Response
    Raanan Greenman, Yoav Pizam, Maya Haus-Cohen, Alona Goor, Guy Horev, Galit Denkberg, Keren Sinik, Yael Elbaz, Vered Bronner, Anat Globerson Levin, Galit Horn, Shai Shen-Orr, Yoram Reiter
    Molecular Cancer Therapeutics Jan 2021, molcanther.MCT-19-1109-A.2019; DOI: 10.1158/1535-7163.MCT-19-1109
  • Anti-tumor activity of NLG207 (formerly CRLX101) in combination with enzalutamide in preclinical prostate cancer models
    Keith T Schmidt, Cindy H. Chau, Jonathan D. Strope, Alwin D.R. Huitema, Tristan M Sissung, Douglas K Price, William D. Figg
    Molecular Cancer Therapeutics Jan 2021, molcanther.0228.2020; DOI: 10.1158/1535-7163.MCT-20-0228
  • PGE2 released by pancreatic cancer cells undergoing ER stress transfers the stress to DCs impairing their immune function.
    Mara Cirone, Maria Saveria Gilardini Montani, Rossella Benedetti, Silvia Piconese, Fabio Maria Pulcinelli, Anna Maria Timperio, Maria Anele Romeo, Gabriella D'Orazi, Laura Masuelli, Maurizio Mattei, Roberto Bei
    Molecular Cancer Therapeutics Jan 2021, molcanther.MCT-20-0699-A.2020; DOI: 10.1158/1535-7163.MCT-20-0699
  • Preclinical Assessment of AMG 596, a BiTE® (Bispecific T-Cell Engager) Immune Therapy Targeting the Tumor-Specific Antigen EGFRvIII
    Alexander Sternjak, Fei Lee, Oliver Thomas, Mercedesz Balazs, Joachim Wahl, Grit Lorenczewski, Ines Ullrich, Markus Muenz, Benno Rattel, Julie M. Ballis, Matthias Friedrich
    Molecular Cancer Therapeutics Jan 2021, molcanther.0508.2020; DOI: 10.1158/1535-7163.MCT-20-0508

Pages

  • Next
  • 1
  • 2
  • 3
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement